TG-C: Clinical Trials

4 trials of TG-C, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 not yet recruiting. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Not yet recruiting 1
Phase 32Active not recruiting 1, Completed 1

Follow TG-C: new trials by email Literature Review of TG-C trials Research Report on TG-C

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Determine the Safety and Efficacy of TG-C in Subjects With Symptomatic Early Hip Osteoarthritis
TG-C, Placebo Control - Degenerative Osteoarthritis
Phase 2Not yet recruitingKolon TissueGene, Inc.2552027-10-012026-08-20
Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the Knee
TG-C, Placebo Control - Degenerative Osteoarthritis
Phase 3CompletedKolon TissueGene, Inc.5312021-12-092026-08-20
A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee
TG-C, Placebo Control - Degenerative Osteoarthritis
Phase 3Active not recruitingKolon TissueGene, Inc.5352018-10-302026-08-20
Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee
TissueGene-C, Normal Saline - Osteoarthritis, Knee
Phase 2CompletedKolon TissueGene, Inc.1022011-05-012016-02-15

Conditions studied

Joint Diseases (3)  ·  Osteoarthritis (1)  ·  Osteoarthritis, Knee (1)

Sponsors

Kolon TissueGene, Inc. (4)

Countries

United States (3)

Top investigators

Moon Jong Noh, PhD (3)  ·  David W Romness, MD (1)  ·  Michael A Mont, MD (1)

Results publications

PMID 26188189, PMID 29145839, PMID 33229973